Macrophage GSK3β-deficiency inhibits the progression of hepatocellular carcinoma and enhances the sensitivity of anti-PD1 immunotherapy.
Sun G, Liu H, Zhao J, Zhang J, Huang T, Sun G, Zhao S, Zhang Z, Cao H, Rong D, Kong X, Ji Q, Liu L, Wang X, Tang W, Xia Y.
Sun G, et al. Among authors: zhao j, zhao s.
J Immunother Cancer. 2022 Dec;10(12):e005655. doi: 10.1136/jitc-2022-005655.
J Immunother Cancer. 2022.
PMID: 36600662
Free PMC article.